- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07947511
Oral-Challenge Study: Steady-State High-ORP Water/Gel Relieves AITC- and Capsaicin-Induced Oral Pain in Healthy Volunteers
Evaluation of Steady-State High-Oxidation-Reduction-Potential Water and Gel for Relief of Oral Pain, Burning and Choking Sensation Provoked by AITC (Wasabi/Horseradish) and Capsaicin (Chili) Among Healthy Human Volunteers
To evaluate the efficacy and safety of stabilized 780±21 mV high-oxidation-potential water to rapidly relieve oral mucosal pain and irritation induced by AITC (wasabi-horseradish) and capsaicin (chili-oil), which activate TRPA1 and TRPV1 sensory ion-channels. Healthy volunteers receive oral 40 mL stabilized high-oxidation-potential water after oral irritant challenge. Pain-irritation NRS scores are assessed at baseline, 3 seconds, 30 seconds, 60 seconds, 120 seconds post-treatment. Safety observations are recorded throughout the study.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
This is prospective, single-arm, open-label exploratory pilot study in healthy adult volunteers. Two separate oral irritant challenge models are applied: AITC-containing horseradish-wasabi challenge for TRPA1-mediated oral irritation-pain; capsaicin-containing chili-oil challenge for TRPV1-mediated burning oral pain. Total target enrollment is 24 healthy subjects (12 male,12 female). After irritant exposure, subjects take 40 mL stabilized 780±21 mV high-oxidation-potential water, hold in mouth then swallow. Subject-reported 0-10 NRS pain-irritation scores are collected at pre-challenge baseline; post-irritant baseline; 3 s,30 s,60 s,120 s after study product administration. Local oral-mucosal adverse reactions and systemic tolerability are monitored. Pre-existing rabbit ocular-surface safety testing supports mucosal safety of this formulation. This trial focuses on acute seconds-range symptom relief in experimental irritant-pain models.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Mizhou Hui
- Número de teléfono: 13484005199
- Correo electrónico: mizhou.hui@alumni.utoronto.ca
Ubicaciones de estudio
-
-
Shandong
-
Qingdao, Shandong, Porcelana, 266000
- Hynaut Laboratory
-
Contacto:
- Xiaoxiao Jia
- Número de teléfono: 15621486915
- Correo electrónico: 15621486915@163.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Healthy adult volunteers aged 18-60 years old, male and female.
- Body weight range 40 kg-72 kg.
- No active oral-pharyngeal disease, no oral ulcer, gingivitis, pharyngitis at screening.
- Able to understand trial procedure, independently complete NRS numeric rating scale assessments.
- Voluntarily provide written informed consent.
Exclusion Criteria:
- Active oral ulcer, stomatitis, gingival-periodontal acute disease, active pharyngitis.
- Known hypersensitivity to electrolyzed saline / study formulation components.
- Gastro-esophageal reflux disease, active gastrointestinal disorder.
- Pregnant or lactating women.
- Recent consumption (<72 hours) of large-dose spicy / irritant food interfering with pain perception.
- Concurrent participation in other oral-pain or mucosal-related clinical research.
- Psychiatric condition impairing study compliance.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Stabilized High-Oxidation-Potential Oral Water
|
Intervention description: Stabilized electrolyzed saline water with oxidation-potential 780±21 mV. After oral irritant challenge (AITC-horseradish-wasabi or capsaicin-chili-oil), subject takes 40 mL of study liquid, holds in oral cavity briefly then swallow, single administration for each challenge test. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
AITC-Induced Oral Pain-Irritation NRS Score
Periodo de tiempo: Post-irritant baseline, 3 seconds, 30 seconds post-product administration.
|
Participant self-reported 0-10 numerical rating scale for oral pain, stinging, choking-irritation triggered by AITC-containing horseradish-wasabi; 0 = no pain/irritation, 10 = worst imaginable oral irritation-pain. |
Post-irritant baseline, 3 seconds, 30 seconds post-product administration.
|
|
Capsaicin-Induced Oral Burning-Pain NRS Score
Periodo de tiempo: Post-irritant baseline, 3 seconds, 30 seconds, 60 seconds,120 seconds post-product administration.
|
Participant self-reported 0-10 NRS for burning-pain triggered by capsaicin-containing chili-oil; 0 = no burning-pain,10 = worst imaginable burning-pain. |
Post-irritant baseline, 3 seconds, 30 seconds, 60 seconds,120 seconds post-product administration.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Participant Overall Subjective Relief Assessment Score
Periodo de tiempo: 120 seconds after product administration for each irritant challenge.
|
Subject-rated 0-10 scale for overall subjective relief of oral discomfort after each challenge test;0=no relief,10=complete relief. |
120 seconds after product administration for each irritant challenge.
|
|
Incidence of Adverse Events
Periodo de tiempo: Throughout entire study visit period (within 30 minutes of product exposure).
|
Incidence of product-related adverse events including oral mucosal stinging, numbness, gastrointestinal upset, throat irritation, nausea. |
Throughout entire study visit period (within 30 minutes of product exposure).
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- HO-ORP-2026-01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .